Benzinga | Aug 4, 2020 04:01PM EDT

Acorda Therapeutics Q2 EPS $(0.35) Beats $(0.48) Estimate, Sales $33.62M Beat $27.50M Estimate

Acorda Therapeutics (NASDAQ:ACOR) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.48) by 27.08 percent. This is a 36.36 percent increase over losses of $(0.55) per share from the same period last year. The company reported quarterly sales of $33.62 million which beat the analyst consensus estimate of $27.50 million by 22.24 percent. This is a 32.84 percent decrease over sales of $50.05 million the same period last year.